Anzeige
Mehr »
Mittwoch, 29.10.2025 - Börsentäglich über 12.000 News
Die 80-Milliarden-Dollar-Nuklear-Renaissance: Warum Uran der heißeste Sektor der Welt ist
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PHDZ | ISIN: AU0000043945 | Ticker-Symbol: PBN
Frankfurt
29.10.25 | 08:09
0,005 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
ALTERITY THERAPEUTICS LIMITED Chart 1 Jahr
5-Tage-Chart
ALTERITY THERAPEUTICS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
0,0050,00921:48

Aktuelle News zur ALTERITY THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
21.10.ALTERITY THERAPEUTICS LTD - 6-K, Report of foreign issuer1
21.10.ALTERITY THERAPEUTICS LIMITED: Notice of Annual General Meeting/Proxy Form2
14.10.ALTERITY THERAPEUTICS LIMITED: Change in substantial holding2
09.10.Alterity Therapeutics stock rises after positive MSA trial data presented at conference3
09.10.ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders3
09.10.ALTERITY THERAPEUTICS LTD - 6-K, Report of foreign issuer1
09.10.ALTERITY THERAPEUTICS LIMITED: Alterity Presents Positive ATH434 Data at 2025 MDS Congress1
02.10.ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson's Disease and Movement Disorders3
ALTERITY THERAPEUTICS Aktie jetzt für 0€ handeln
02.10.ALTERITY THERAPEUTICS LTD - 6-K, Report of foreign issuer1
02.10.ALTERITY THERAPEUTICS LIMITED: Alterity to Deliver Multiple Presentations at MDS Conference-
29.09.ALTERITY THERAPEUTICS LIMITED: Alterity Reports New Commercial Assessment for ATH434 in MSA2
23.09.ALTERITY THERAPEUTICS LTD - 6-K, Report of foreign issuer-
23.09.ALTERITY THERAPEUTICS LIMITED: Date of AGM and Closing Date for Director Nominations-
17.09.ALTERITY THERAPEUTICS LIMITED: Change of Director's Interest Notice x 4-
17.09.ALTERITY THERAPEUTICS LIMITED: Notification of cessation of securities - ATH2
17.09.ALTERITY THERAPEUTICS LIMITED: Change in substantial holding2
15.09.'Tough nut to crack', but expert tips Alterity's MSA drug as potential game changer3
15.09.ALTERITY THERAPEUTICS LTD - 6-K, Report of foreign issuer1
15.09.ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting2
15.09.ALTERITY THERAPEUTICS LIMITED: Alterity Presents Phase 2 Data at US Neurology Meeting2
Weiter >>
86 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1